Skip to main content
Inspire Medical Systems, Inc. logo

Inspire Medical Systems, Inc. — Investor Relations & Filings

Ticker · INSP ISIN · US4577301090 LEI · 549300XQQCQ7HCJKTW25 US Manufacturing
Filings indexed 838 across all filing types
Latest filing 2026-05-04 Interim / Quarterly Rep…
Country US United States of America
Listing US INSP

About Inspire Medical Systems, Inc.

https://www.inspiresleep.com/

Inspire Medical Systems, Inc. is a medical technology company that develops and commercializes minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its core product, Inspire® therapy, is the first FDA-approved implantable neurostimulation system for treating moderate to severe OSA. The therapy is intended for patients who are unable to use or get consistent benefit from Continuous Positive Airway Pressure (CPAP) treatment. The system works by monitoring breathing patterns and delivering mild stimulation to the hypoglossal nerve, which moves the tongue forward to keep the airway open during sleep. The patient-controlled system consists of an implantable device, a remote, and a companion app, providing a mask-free and hose-free alternative to traditional OSA treatments.

Recent filings

Filing Released Lang Actions
10-Q - Inspire Medical Systems, Inc. (0001609550) (Filer)
Interim / Quarterly Report
2026-05-04 English
8-K - Inspire Medical Systems, Inc. (0001609550) (Filer)
Regulatory Filings
2026-05-04 English
SCHEDULE 13G/A - Inspire Medical Systems, Inc. (0001609550) (Subject)
Major Shareholding Notification
2026-03-27 English
ARS - Inspire Medical Systems, Inc. (0001609550) (Filer)
Annual Report
2026-03-20 English
DEFA14A - Inspire Medical Systems, Inc. (0001609550) (Filer)
Regulatory Filings
2026-03-20 English
DEF 14A - Inspire Medical Systems, Inc. (0001609550) (Filer)
Proxy Solicitation & Information Statement
2026-03-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.